Option to Co-Promote. (a) Schering-Plough hereby grants to AVEO an option (the “Co-Promotion Option”) to co-promote the Licensed Product in the United States for an oncology Indication which is the subject of the First Product Filing (the “Co-Promotion Indication”) in accordance with a co-promotion agreement (the “Co-Promotion Agreement”) to be negotiated by the Parties. The Co-Promotion Agreement will include the material terms set forth in Exhibit C.
Option to Co-Promote. Kissei retains the option to negotiate for co-promotion rights in the Field in the Territory until * after the submission of the first NDA for the first Product (in the Territory, subject to any restrictions on co-promotions rights under applicable Law in the Territory. If Kissei wishes to exercise this option right, the Parties shall negotiate and attempt to agree and enter into a co-promotion agreement within * or alternatively Elixir may decline to negotiate with Kissei. Elixir may at any time inform Kissei that Elixir is terminating Kissei’s option because Elixir desires to negotiate with others. If Kissei fails to exercise such option before the end of such * period or if the Parties are unable to agree within such * day period or if Elixir so declines to negotiate or so terminates the option, Kissei will no longer have any rights and Elixir will no longer have any obligations under this Section 8.5.
Option to Co-Promote. MPC shall have the option to participate in the promotion of the Product in the MN Territory, on terms to be agreed to by MN. The Parties will negotiate in good faith to enter into a co-promotion agreement within six (6) months of an NDA filing in the United States and an MAA in the Major European Countries. In case co-promotion is prevented by laws or other regulations in a particular country in the MN Territory, the Parties agree to initiate discussions on how to provide MPC with similar rights in a legally acceptable fashion. ** CERTAIN INFORMATION (INDICATED BY ASTERISKS) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION.
Option to Co-Promote. (a) In General. BMS hereby grants to Exelixis the first and exclusive option (a “Co-Promotion Option”) to co-promote each Co-Developed Product in the U.S. in accordance with a co-promotion agreement (the “Co-Promotion Agreement”) to be negotiated in good faith by the Parties [ * ] subsequent to Exelixis’ exercise of the Co-Promotion Option with respect to a particular Co-Developed Product.
Option to Co-Promote. Kissei retain the option to participate in the promotion of the Product in the MediciNova Territory, on terms to be agreed to by MediciNova. Both Parties will negotiate in good faith to enter into a co-promotion agreement within 6 months of an NDA filing in the United States and the Major European Countries.
Option to Co-Promote. MPC shall have the option to participate in the promotion of the Product in the MN Territory, on terms to be agreed to by MN. The Parties will negotiate in good faith to enter into a co-promotion agreement within six (6) months of an NDA filing in the United States and an MAA in the Major European Countries. In case co-promotion is prevented by laws or other regulations in a particular country in the MN Territory, the Parties agree to initiate discussions on how to provide MPC with similar rights in a legally acceptable fashion.
Option to Co-Promote. Kissei retains the option to participate in the promotion of the Product in the United States by itself or through its Affiliates, in accordance with the following:
Option to Co-Promote. The Lead Marketing Party with respect to a particular Collaboration Product shall give the Passive Marketing Party [*] written notice of the anticipated date of commercial launch of such Collaboration Product. The Passive Marketing Party shall have the right, but not the obligation, to co-promote such Collaboration Product on a country-by-country basis, commencing at any time from the date of commercial launch of such Collaboration Product in the first country, by providing [*] advance written notice to the Lead Marketing Party.
Option to Co-Promote. (a) With respect to each [***] (each a “Co-Promote Product”), GNE hereby grants to SGEN an option (a “Co-Promotion Option”) to Co-Promote such Co-Promote Product in the U.S. in accordance with Section 6.6(d) and the Co-Promotion Plan (as agreed to in accordance with Section 6.6(c)). Such Co-Promotion Option shall be exercised as provided in Section 6.6(b).
Option to Co-Promote. (a) Licensee hereby grants to Anacor an option (a "Co-Promotion Option") to co-promote the Licensed Product in the Lead Indication in the United States to the Co-Promotion Target Audience in accordance with a co-promotion agreement (a "Co-Promotion Agreement") to be negotiated by the Parties. The Co-Promotion Agreement will include the material terms described on Exhibit 6.2.
